Design and Evaluation of Niosomal Gel Delivery Systems for Topical
... urticaria, burning, and general irritation of the skin, and cramps2. Nowadays, niosomes play an increasingly important role in drug delivery as they can reduce toxicity and modify drug pharmacokinetics and bioavailability. Niosomes seem an interesting drug delivery system in the treatment of dermato ...
... urticaria, burning, and general irritation of the skin, and cramps2. Nowadays, niosomes play an increasingly important role in drug delivery as they can reduce toxicity and modify drug pharmacokinetics and bioavailability. Niosomes seem an interesting drug delivery system in the treatment of dermato ...
B26007011
... biosystems and which uses biological principles and materials to create new devices and systems integrated from the nanoscale and in particular its applications in the medical sector are considered as one of the most promising and most advanced areas of nanotechnology. Applications include e.g. nano ...
... biosystems and which uses biological principles and materials to create new devices and systems integrated from the nanoscale and in particular its applications in the medical sector are considered as one of the most promising and most advanced areas of nanotechnology. Applications include e.g. nano ...
Nanocochleate - a new approach in lipid drug delivery
... reconstituted with liquid prior to administration. Cochleate is most versatile technology for the delivery of a wide range of drugs and fragile molecules such as proteins and peptides . Cochleates are calcium‐phospholipid structures composed of naturally occurring ...
... reconstituted with liquid prior to administration. Cochleate is most versatile technology for the delivery of a wide range of drugs and fragile molecules such as proteins and peptides . Cochleates are calcium‐phospholipid structures composed of naturally occurring ...
role of biodegradable polymers in drug delivery
... JAY R. JOSHI*, RONAK P. PATEL Department of Pharmaceutics, A.R. College of Pharmacy Vallabh Vidhyanagar , Gujarat, India. Email:[email protected] Received: 25 August 2012, Revised and Accepted: 18 September 2012 ABSTRACT The current review article focuses on Biodegradable polymers in pharmaceuti ...
... JAY R. JOSHI*, RONAK P. PATEL Department of Pharmaceutics, A.R. College of Pharmacy Vallabh Vidhyanagar , Gujarat, India. Email:[email protected] Received: 25 August 2012, Revised and Accepted: 18 September 2012 ABSTRACT The current review article focuses on Biodegradable polymers in pharmaceuti ...
IB Formulation Technologies
... • Final commercial dose is not available until the completion of clinical trials, so it is important to understand the feasible concentration window for the protein of interest. • In general, the concentration is not as critical for intravenous delivery products as subcutaneous or intramuscular deli ...
... • Final commercial dose is not available until the completion of clinical trials, so it is important to understand the feasible concentration window for the protein of interest. • In general, the concentration is not as critical for intravenous delivery products as subcutaneous or intramuscular deli ...
th Central European Symposium on Pharmaceutical Technology
... the face of diagnostics, therapeutics, and drug delivery systems Three round table meetings, entitled Alpe Adria Seminars on throughout the biomedical field. The challenges generated by Pharmaceutical Technology, were held. these new concepts and achievements in pharmaceutical techIn 1993, when the ...
... the face of diagnostics, therapeutics, and drug delivery systems Three round table meetings, entitled Alpe Adria Seminars on throughout the biomedical field. The challenges generated by Pharmaceutical Technology, were held. these new concepts and achievements in pharmaceutical techIn 1993, when the ...
Microneedles - cloudfront.net
... employ the use of a syringe. About 12 products based on microneedle technology are currently in clinical development, more than half of which are in phase II or a higher stage of development. In addition, there are a number of other products currently in preclinical trials. Many academic institution ...
... employ the use of a syringe. About 12 products based on microneedle technology are currently in clinical development, more than half of which are in phase II or a higher stage of development. In addition, there are a number of other products currently in preclinical trials. Many academic institution ...
Inhalation Drug Delivery ‐
... Inhalation drug delivery is advantageous for local delivery due to a reduction in systemic side effects. It is also advantageous for systemic delivery due to rapid and complete absorption by the alveolar capillaries as well as prevention of hepatic fist pass metabolism. Ideal drug candidates f ...
... Inhalation drug delivery is advantageous for local delivery due to a reduction in systemic side effects. It is also advantageous for systemic delivery due to rapid and complete absorption by the alveolar capillaries as well as prevention of hepatic fist pass metabolism. Ideal drug candidates f ...
Design and Evaluation of Diclofenac Sodium Ocusert
... with an initial period of overdosing, followed by a longer period of underdosing1, 2. Consequently, numerous novel ophthalmic drug delivery systems were developed to achieve a higher bioavailability of drugs. Among these formulations are in situ gelling polymer3-6, microspheres711 , nanoparticles12- ...
... with an initial period of overdosing, followed by a longer period of underdosing1, 2. Consequently, numerous novel ophthalmic drug delivery systems were developed to achieve a higher bioavailability of drugs. Among these formulations are in situ gelling polymer3-6, microspheres711 , nanoparticles12- ...
Transdermal Delivery Systems
... • Scheindlin Stanley Transdermal drug delivery: PAST, PRESENT, FUTURE. Molecular interventions (2004), 4(6), 308-12 (see link in presentation). • Prausnitz, Mark R.; Langer, Robert. Transdermal drug delivery. Nature Biotechnology (2008), 26(11), 12611268 Link • Sieg, A.; Wascotte, V. Diagnostic and ...
... • Scheindlin Stanley Transdermal drug delivery: PAST, PRESENT, FUTURE. Molecular interventions (2004), 4(6), 308-12 (see link in presentation). • Prausnitz, Mark R.; Langer, Robert. Transdermal drug delivery. Nature Biotechnology (2008), 26(11), 12611268 Link • Sieg, A.; Wascotte, V. Diagnostic and ...
annexure-ii
... and delayed ischemia onset without significantly modifying heart rate, blood pressure or both4.Because of its high solubility, short half life(6±1.4 hrs)5 and therapeutic use in chronic disease it is considered as an ideal drug candidate for the design of oral controlled release dosage form. The use ...
... and delayed ischemia onset without significantly modifying heart rate, blood pressure or both4.Because of its high solubility, short half life(6±1.4 hrs)5 and therapeutic use in chronic disease it is considered as an ideal drug candidate for the design of oral controlled release dosage form. The use ...
FORMULATION AND OPTIMISATION OF GASTRO RETENTIVE DRUG DELIVERY SYSTEM CONTAINING GLIPIZIDE
... The friability was below 1% for all the formulations, which is an indication of good mechanical resistance of the tablets. The drug content for all the formulations were found to be in the range of 92.94% to 101.52%. The buoyancy lag time was in the range of 36s to 61s. The floating time of the form ...
... The friability was below 1% for all the formulations, which is an indication of good mechanical resistance of the tablets. The drug content for all the formulations were found to be in the range of 92.94% to 101.52%. The buoyancy lag time was in the range of 36s to 61s. The floating time of the form ...
Design of colon specific drug delivery systems.
... Eudragit L100 and Eudragit S100 been prepared in isopropyl alcohol: water (9:1) mixture. The ratios of Eudragit S100: Eudragit L100 were 1:4. The resulted suspension was coated on matrix tablet using coating pan. Coated tablets were removed from the apparatus when the coating loads reached 20% (w/w) ...
... Eudragit L100 and Eudragit S100 been prepared in isopropyl alcohol: water (9:1) mixture. The ratios of Eudragit S100: Eudragit L100 were 1:4. The resulted suspension was coated on matrix tablet using coating pan. Coated tablets were removed from the apparatus when the coating loads reached 20% (w/w) ...
chronomodulated drug delivery system
... Harshida G Patel*, Karishma Patel, UM Upadhyay, Viral H Shah Sigma Institute of Pharmacy, Bakrol, Waghodiya, Vadodara, Gujrat, India. ABSTRACT In this review, the concepts of biological rhythms, chronobiology, chronopharmacology, and chronotherapy for various diseases have been discussed. Chronophar ...
... Harshida G Patel*, Karishma Patel, UM Upadhyay, Viral H Shah Sigma Institute of Pharmacy, Bakrol, Waghodiya, Vadodara, Gujrat, India. ABSTRACT In this review, the concepts of biological rhythms, chronobiology, chronopharmacology, and chronotherapy for various diseases have been discussed. Chronophar ...
Household Items That May Contain Mercury
... determined the illegal use of hazardous materials the game plan changes. A clandestine drug laboratory (CDL), in law enforcement parlance, is an illegal and covert operation that produces a controlled substance by chemical reactions. Hazardous materials responders must be able to recognize a drug la ...
... determined the illegal use of hazardous materials the game plan changes. A clandestine drug laboratory (CDL), in law enforcement parlance, is an illegal and covert operation that produces a controlled substance by chemical reactions. Hazardous materials responders must be able to recognize a drug la ...
FreeDownloadPowerPoint.Com
... Factors influences this system • Microchannel density: By increasing the microchannel density (MCs/cm2 ), a higher amount of drug can be delivered in efficient manner. • Duration of delivery: The drug delivery can be enhanced up to 24 h using this technology • Dosage forms: A patch is the most conv ...
... Factors influences this system • Microchannel density: By increasing the microchannel density (MCs/cm2 ), a higher amount of drug can be delivered in efficient manner. • Duration of delivery: The drug delivery can be enhanced up to 24 h using this technology • Dosage forms: A patch is the most conv ...
Application of the Purdue Ontology for Pharmaceutical Engineering
... information, possible through the ontological approach, is useful for interaction prediction in pharmaceutical product development. ...
... information, possible through the ontological approach, is useful for interaction prediction in pharmaceutical product development. ...
article pdf - ONdrugDelivery
... Surgery at the University of Kentucky, served on the faculty of Tufts University, and worked as a Pharmaceutical Scientist at Hoffman-La Roche. Dr Ashton received a BSc in Chemistry from Durham University (UK), and a PhD in Pharmaceutical Science from the University of Wales. ...
... Surgery at the University of Kentucky, served on the faculty of Tufts University, and worked as a Pharmaceutical Scientist at Hoffman-La Roche. Dr Ashton received a BSc in Chemistry from Durham University (UK), and a PhD in Pharmaceutical Science from the University of Wales. ...
Engineering Simulation Solutions for the Biomed Industry
... their simulation partner, deploying the world’s most comprehensive multiphysics solutions to solve their complex engineering challenges. The engineered scalability of our solutions delivers the flexibility customers need, within an architecture that is adaptable to the processes and design systems o ...
... their simulation partner, deploying the world’s most comprehensive multiphysics solutions to solve their complex engineering challenges. The engineered scalability of our solutions delivers the flexibility customers need, within an architecture that is adaptable to the processes and design systems o ...
sensitive, selective and rapid high performance liquid
... 1. Mahore J G et al., Ion exchange resins are cross-linked water insoluble polymercarrying, ionizable functional groups. IER have received considerable attention from pharmaceutical scientists because of their versatile properties as drug delivery vehicles. Research over the last few years has revea ...
... 1. Mahore J G et al., Ion exchange resins are cross-linked water insoluble polymercarrying, ionizable functional groups. IER have received considerable attention from pharmaceutical scientists because of their versatile properties as drug delivery vehicles. Research over the last few years has revea ...
medical device development and testing
... Medical Device Development and Testing Southwest Research Institute® (SwRI®) offers expertise in diverse areas such as biomaterials and tissue engineering, materials characterization, biological encapsulation, and medical device development. Scientists in the Materials and Bioengineering Section hav ...
... Medical Device Development and Testing Southwest Research Institute® (SwRI®) offers expertise in diverse areas such as biomaterials and tissue engineering, materials characterization, biological encapsulation, and medical device development. Scientists in the Materials and Bioengineering Section hav ...
Neurology Firm NuPathe Gets $15M For Lead Migraine Patch
... considering about 30 million people suffer from migraines, but many do not seek treatment. NuPathe licensed the patch technology used in NP101 from Minneapolis-based Iontophoresis. A second platform technology, used in two follow-on products, was licensed from the University of Pennsylvania in Phila ...
... considering about 30 million people suffer from migraines, but many do not seek treatment. NuPathe licensed the patch technology used in NP101 from Minneapolis-based Iontophoresis. A second platform technology, used in two follow-on products, was licensed from the University of Pennsylvania in Phila ...
RadioPharmaceuticals
... better bioavailability & targeting properties & for reducing the toxicity & side effects of drugs. •Niosomes can be transported by macrophages which are known to infiltrate tumour cells. ...
... better bioavailability & targeting properties & for reducing the toxicity & side effects of drugs. •Niosomes can be transported by macrophages which are known to infiltrate tumour cells. ...
Nicholas A. Peppas
Nicholas (Nikolaos) A. Peppas (Greek: Νικόλαος Α. Πέππας; born in Athens, Greece on August 25, 1948) is a chemical and biomedical engineer whose leadership in biomaterials science and engineering, drug delivery, bionanotechnology, pharmaceutical sciences, chemical and polymer engineering has led to numerous biomedical products or devices.